Across TCGA pan-cancer cohorts, MTND6P7 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated MTND6P7 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MTND6P7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTND6P7 expression acts as an unfavorable survival marker.

KIRC and UCS are the cancer types where MTND6P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.146	0.659	<.001	84	view →
UCS	OS	Tertile	All	0.135	0.687	.009	72	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MTND6P7 tumor-vs-normal RNA expression · all MTND6P7 data types